Oral Transmucosal Drugs Global Market Report 2025

Description

Oral transmucosal drugs are medications designed to be absorbed through the mucous membranes in the mouth, offering rapid effects while bypassing initial metabolism in the liver and gastrointestinal tract. These drugs are commonly utilized for conditions requiring swift relief, such as pain management, and for patients facing challenges with swallowing pills.

The primary types of oral transmucosal drugs include tablets, films, liquid formulations, sprays, and other related forms. Tablets within this category are solid dosage forms intended for administration through the mucous membranes in the mouth. They are indicated for various conditions such as opioid dependence, nausea and vomiting, erectile dysfunction, neurological disorders, and others, typically administered via the sublingual or buccal mucosa routes and distributed through hospital pharmacies, retail pharmacies, and online platforms.

The oral transmucosal drugs market research report is one of a series of new reports from The Business Research Company that provides oral transmucosal drugs market statistics, including oral transmucosal drugs industry global market size, regional shares, competitors with oral transmucosal drugs market share, detailed oral transmucosal drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the oral transmucosal drugs industry. This oral transmucosal drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The oral transmucosal drugs market size has grown strongly in recent years. It will grow from $39.7 billion in 2024 to $43.53 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to advancements in diagnostic capabilities, aging demographics, environmental pollutants, genetic susceptibilities, enhanced detection rates, faster relief facilitated by fast drug absorption, and better adherence.

The oral transmucosal drugs market size is expected to see strong growth in the next few years. It will grow to $62.03 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to advancements in personalized medicine, increasing research on novel drug delivery systems, expanding geriatric population, growing awareness of oral health, rising demand for non-invasive treatments, and evolving regulatory landscapes. Major trends in the forecast period include adoption of novel formulations, personalized medicine approaches, telehealth advancements, integration of digital health technologies and technological innovations in pharmaceuticals.

The growth of the oral transmucosal drug market is expected to be driven by the increasing incidence of Parkinson's disease. Parkinson's disease is a progressive neurological disorder characterized by tremors, stiffness, and movement difficulties due to a decline in dopamine-producing cells in the brain. Factors contributing to the rising prevalence of Parkinson's disease include aging populations, environmental pollutants, genetic vulnerabilities, and improved diagnostic capabilities that enhance detection rates. Oral transmucosal drugs play a crucial role in supporting Parkinson's disease treatment by enabling rapid drug absorption and overcoming digestive challenges, resulting in quicker relief, improved adherence, and potentially fewer motor complications. For example, the Parkinson's Foundation reported that approximately 1 million individuals in the United States currently have Parkinson's disease, expected to rise to 1.2 million by 2030. This trend underscores how the increasing incidence of Parkinson's disease is fueling the expansion of the oral transmucosal drug market.

Leading companies in the oral transmucosal drug market are focused on developing innovative drug delivery solutions, such as sublingual vitamin sprays, to enhance drug delivery efficiency, enhance patient convenience, and optimize therapeutic outcomes. A sublingual vitamin spray is a drug delivery system that delivers vitamins directly into the bloodstream through the mucous membranes under the tongue, bypassing the gastrointestinal tract and liver metabolism for rapid and efficient absorption. For instance, Vestige Marketing introduced Absorvit in October 2022, a sublingual vitamin spray that offers swift absorption and rapid results, providing 3-10 times greater absorption than traditional oral methods. It contains upgraded forms and precise doses of essential vitamins, including B12, C, D, and multivitamins, ensuring optimal nutrient delivery for improved wellness.

In January 2024, XOMA Corporation acquired DSUVIA from Talphera, Inc. for $8 million, aiming to capitalize on revenue from DSUVIA, a sufentanil sublingual tablet, while collaborating with Talphera and leveraging potential milestones from Alora Pharmaceuticals in the development of oral transmucosal drugs. Talphera Inc. is a pharmaceutical company involved in oral transmucosal drug development.

Major companies operating in the oral transmucosal drugs market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi-Aventis LLC, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Eli Lilly & Company Ltd., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Actavis Pharma Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Mallinckrodt Pharmaceuticals Plc, Glenmark Pharmaceuticals Limited, Jubilant Life Sciences Limited, Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd, Wockhardt Ltd.

North America was the largest region in the oral transmucosal drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral transmucosal drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral transmucosal drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral transmucosal drugs market consists of sales of buccal patches, sublingual tablets, lozenges, and oral transmucosal powders. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Transmucosal Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral transmucosal drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral transmucosal drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral transmucosal drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Tablets; Films; Liquid And Spray; Other Product Types
2) By Indication: Opioid Dependence; Nausea And Vomiting; Erectile Dysfunction; Neurological Disorders; Other Indications
3) By Route Of Administration: Sublingual Mucosa; Buccal Mucosa; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Tablets: Buccal Tablets; Sublingual Tablets; Effervescent Tablets
2) By Films: Buccal Films; Sublingual Films; Mucoadhesive Films
3) By Liquid And Spray: Sublingual Liquid Solutions; Oral Sprays (Pain Relief, Sleep Aids); Mucosal Gels
4) By Other Product Types: Lozenges; Pastilles; Chewing Gums
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Sanofi-Aventis LLC; AstraZeneca PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30849

1. Executive Summary

2. Oral Transmucosal Drugs Market Characteristics

3. Oral Transmucosal Drugs Market Trends And Strategies

4. Oral Transmucosal Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Oral Transmucosal Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Oral Transmucosal Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Oral Transmucosal Drugs Market Growth Rate Analysis
5.4. Global Oral Transmucosal Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Oral Transmucosal Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Oral Transmucosal Drugs Total Addressable Market (TAM)

6. Oral Transmucosal Drugs Market Segmentation

6.1. Global Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Films
Liquid And Spray
Other Product Types
6.2. Global Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Opioid Dependence
Nausea And Vomiting
Erectile Dysfunction
Neurological Disorders
Other Indications
6.3. Global Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sublingual Mucosa
Buccal Mucosa
Other Routes Of Administration
6.4. Global Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Oral Transmucosal Drugs Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Buccal Tablets
Sublingual Tablets
Effervescent Tablets
6.6. Global Oral Transmucosal Drugs Market, Sub-Segmentation Of Films, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Buccal Films
Sublingual Films
Mucoadhesive Films
6.7. Global Oral Transmucosal Drugs Market, Sub-Segmentation Of Liquid And Spray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sublingual Liquid Solutions
Oral Sprays (Pain Relief, Sleep Aids)
Mucosal Gels
6.8. Global Oral Transmucosal Drugs Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lozenges
Pastilles
Chewing Gums

7. Oral Transmucosal Drugs Market Regional And Country Analysis

7.1. Global Oral Transmucosal Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Oral Transmucosal Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oral Transmucosal Drugs Market

8.1. Asia-Pacific Oral Transmucosal Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oral Transmucosal Drugs Market

9.1. China Oral Transmucosal Drugs Market Overview
9.2. China Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oral Transmucosal Drugs Market

10.1. India Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oral Transmucosal Drugs Market

11.1. Japan Oral Transmucosal Drugs Market Overview
11.2. Japan Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oral Transmucosal Drugs Market

12.1. Australia Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oral Transmucosal Drugs Market

13.1. Indonesia Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oral Transmucosal Drugs Market

14.1. South Korea Oral Transmucosal Drugs Market Overview
14.2. South Korea Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oral Transmucosal Drugs Market

15.1. Western Europe Oral Transmucosal Drugs Market Overview
15.2. Western Europe Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oral Transmucosal Drugs Market

16.1. UK Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oral Transmucosal Drugs Market

17.1. Germany Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oral Transmucosal Drugs Market

18.1. France Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oral Transmucosal Drugs Market

19.1. Italy Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oral Transmucosal Drugs Market

20.1. Spain Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oral Transmucosal Drugs Market

21.1. Eastern Europe Oral Transmucosal Drugs Market Overview
21.2. Eastern Europe Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oral Transmucosal Drugs Market

22.1. Russia Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oral Transmucosal Drugs Market

23.1. North America Oral Transmucosal Drugs Market Overview
23.2. North America Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oral Transmucosal Drugs Market

24.1. USA Oral Transmucosal Drugs Market Overview
24.2. USA Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oral Transmucosal Drugs Market

25.1. Canada Oral Transmucosal Drugs Market Overview
25.2. Canada Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oral Transmucosal Drugs Market

26.1. South America Oral Transmucosal Drugs Market Overview
26.2. South America Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oral Transmucosal Drugs Market

27.1. Brazil Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oral Transmucosal Drugs Market

28.1. Middle East Oral Transmucosal Drugs Market Overview
28.2. Middle East Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oral Transmucosal Drugs Market

29.1. Africa Oral Transmucosal Drugs Market Overview
29.2. Africa Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oral Transmucosal Drugs Market Competitive Landscape And Company Profiles

30.1. Oral Transmucosal Drugs Market Competitive Landscape
30.2. Oral Transmucosal Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Oral Transmucosal Drugs Market Other Major And Innovative Companies

31.1. Abbott Laboratories
31.2. Novartis AG
31.3. GlaxoSmithKline plc
31.4. Eli Lilly & Company Ltd.
31.5. Boehringer Ingelheim International GmbH
31.6. Viatris Inc.
31.7. Teva Pharmaceutical Industries Ltd.
31.8. Biogen Inc.
31.9. Actavis Pharma Inc.
31.10. Sun Pharmaceutical Industries Limited
31.11. Dr. Reddy's Laboratories Ltd.
31.12. Endo Pharmaceuticals Inc.
31.13. Lupin Limited
31.14. Zydus Lifesciences Limited
31.15. Mallinckrodt Pharmaceuticals Plc

32. Global Oral Transmucosal Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Transmucosal Drugs Market

34. Recent Developments In The Oral Transmucosal Drugs Market

35. Oral Transmucosal Drugs Market High Potential Countries, Segments and Strategies

35.1 Oral Transmucosal Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Oral Transmucosal Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Oral Transmucosal Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer